Ex-Abbott minister hits out at 'ridiculous MDMA ban'

Andrew Robb says NSW Health's concerns about medicinal ecstasy have been repeatedly proven false. (Flavio Brancaleone/AAP PHOTOS)

Consumers face challenges accessing medicinal ecstasy in NSW, a minister concedes after a strong opponent of recreational drug use and former Abbott government minister condemned a virtual ban on treatment.

In a world-first move in 2023, MDMA and another psychedelic were approved for use in Australia for post-traumatic stress disorder and treatment-resistant depression respectively.

But heavy restrictions by NSW Health on where and how treatment can be administered have left doctors unable to treat in their own clinics and have forced patients to fly interstate for treatment.

"It's just ridiculous," former federal trade minister Andrew Robb told AAP on Wednesday.

"It's incumbent on the department to stop peddling suggestions or justifications which have been proven in 125 (clinical) trials to be totally fallacious".

Former federal minister Andrew Robb
Former coalition minister Andrew Robb has spoken publicly about his long battle with depression.

The regulatory obstacles meant one of the first two people treated with medicinal MDMA in Australia in January, was a NSW resident who had flown to Melbourne for the dosing sessions, along with their psychiatrist and clinical psychologist.

Treatment in NSW is restricted to private health facilities with mental health provisions.

NSW Health's stated concerns had either never been borne out in trials or were integral parts of the treatment, Mr Robb said.

The long-time coalition MP and former federal Liberal Party director, who has previously publicly detailed his long battle with depression, described himself as a strong opponent of drugs for recreational purposes.

But he said the evidence was clear about the ability of MDMA and psilocybin - a psychedelic agent contained in magic mushrooms - to offer paramedics, war veterans and other patients suffering depression or PTSD a chance at remission, not just relief from symptoms.

Logo of Therapeutic Goods Administration
Medicinal MDMA and psilocybin were approved in 2023 by the Therapeutic Goods Administration.

"I take seven pills a day," the 72-year-old board member of Mind Medicine Australia said.

"I'm sick of it, totally sick of it and all it does is provide relief. It doesn't fix the problem."

Legalise Cannabis MP Jeremy Buckingham said NSW had struck the wrong balance between guarding against adverse events and providing relief to people whose lives had become unbearable.

"It's causing untold needless suffering and loss of life," he told parliament on Wednesday.

Mental Health Minister Rose Jackson, who has met with Mr Robb about his concerns, acknowledged the system was difficult to navigate.

But she said the current measures were essential to ensure the safety of all participants while this treatment method goes through a rigorous research process, as was best practice.

Rose Jackson
Medicinal psychedelic treatment has had limited uptake in NSW, Rose Jackson says

"There are challenges for consumers when it comes to access, which is reflected in the limited uptake in NSW," she told AAP in a statement.

"That is why we are reviewing annually to see where we can make improvements to the system."

Asked if regulations needed to fall into line with neighbouring states, Health Minister Ryan Park said authorities needed to tread carefully in what was a novel area of medicine.

"NSW Health ... are not people who want to try and stop improvements in treatments, but they do want to make sure that we are operating on an evidence base," he said.

Lifeline 13 11 14

beyondblue 1300 22 4636

License this article

What is AAPNews?

For the first time, Australian Associated Press is delivering news straight to the consumer.

No ads. No spin. News straight-up.

Not only do you get to enjoy high-quality news delivered straight to your desktop or device, you do so in the knowledge you are supporting media diversity in Australia.

AAP Is Australia’s only independent newswire service, free from political and commercial influence, producing fact-based public interest journalism across a range of topics including politics, courts, sport, finance and entertainment.

What is AAPNews?
The Morning Wire

Wake up to AAPNews’ morning news bulletin delivered straight to your inbox or mobile device, bringing you up to speed with all that has happened overnight at home and abroad, as well as setting you up what the day has in store.

AAPNews Morning Wire
AAPNews Breaking News
Breaking News

Be the first to know when major breaking news happens.


Notifications will be sent to your device whenever a big story breaks, ensuring you are never in the dark when the talking points happen.

Focused Content

Enjoy the best of AAP’s specialised Topics in Focus. AAP has reporters dedicated to bringing you hard news and feature content across a range of specialised topics including Environment, Agriculture, Future Economies, Arts and Refugee Issues.

AAPNews Focussed Content
Subscription Plans

Choose the plan that best fits your needs. AAPNews offers two basic subscriptions, all billed monthly.

Once you sign up, you will have seven days to test out the service before being billed.

AAPNews Full Access Plan
Full Access
AU$10
  • Enjoy all that AAPNews has to offer
  • Access to breaking news notifications and bulletins
  • Includes access to all AAPNews’ specialised topics
Join Now
AAPNews Student Access Plan
Student Access
AU$5
  • Gain access via a verified student email account
  • Enjoy all the benefits of the ‘Full Access’ plan at a reduced rate
  • Subscription renews each month
Join Now
AAPNews Annual Access Plan
Annual Access
AU$99
  • All the benefits of the 'Full Access' subscription at a discounted rate
  • Subscription automatically renews after 12 months
Join Now

AAPNews also offers enterprise deals for businesses so you can provide an AAPNews account for your team, organisation or customers. Click here to contact AAP to sign-up your business today.

SEVEN DAYS FREE
Download the app
Download AAPNews on the App StoreDownload AAPNews on the Google Play Store